BTI
LGND icon

Blue Trust Inc’s Ligand Pharmaceuticals LGND Stock Holding History

Blue Trust Inc’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948 Hold
3
– – ﹤0.01% 2303
2026
Q1 		$599 Hold
3
– – ﹤0.01% 2321
2025
Q4 		$567 Buy
+3
New +$576 ﹤0.01% 2372
2024
Q4 		– Sell
-56
Closed -$4.72K – 2739
2024
Q3 		$4.72K Buy
56
+37
+195% +$3.73K ﹤0.01% 2415
2024
Q2 		$1.39K Buy
+19
New +$1.51K ﹤0.01% 2503
2024
Q1 		– Sell
-5
Closed – – 2491
2023
Q4 		$0 Buy
+5
New +$295 ﹤0.01% 2610

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blue Trust Inc's LGND Position: Q2 2026 in Review

Blue Trust Inc held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 3 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #2303.

Blue Trust Inc first reported a position in LGND in Q4 2023 and has held it in 6 quarters since. The position peaked at $4.72K in Q3 2024. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Blue Trust Inc held 3 shares of Ligand Pharmaceuticals worth $948 as of Q2 2026.
  • Blue Trust Inc left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2303 holding.
  • Blue Trust Inc first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • Blue Trust Inc's Ligand Pharmaceuticals position peaked at $4.72K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.